Delta4 at BIO-EUROPE 2021
From October 25-28 Delta4 attended the (virtual) BIO-EUROPE conference, the largest partnering event in Europe dedicated to the global biotechnology industry. What is Bio-Europe? The Bio-Europe conference is an annual event that serves as the largest partnering conference in the life sciences sector, focusing on the biotechnology and pharmaceutical industries. The conference, organized by EBD […]
Delta4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board
VIENNA, Austria, September 27th, 2021 — Delta4, a digital drug discovery company focusing on the identification of new indications for existing drug compounds, today announced that Dr. Hans Lehrach will join its Scientific Advisory Board. Prof. Lehrach is a distinguished scientist in the area of genomics. „We are excited to have Dr. Lehrach join our […]
FSGS and COVID-19 programs ready for Phase II studies
We are proud to announce further progress in our current drug discovery and development programs. In late 2020, Delta4 filed four patent applications for compounds and combinations of compounds for the treatment of FSGS, a rare kidney disease with only limited therapeutic options, and COVID-19. Today, drug candidates from both programs have been biologically validated […]
Delta4 files four patent applications in FSGS and COVID-19
We are very pleased to announce that Delta4 has filed four patent applications for compounds and combinations of compounds in our drug discovery programs in FSGS and COVID-19. FSGS, or Focal Segmental Glomerulosclerosis, is a devastating renal disease with high and urgent medical need. We initiated our discovery program in this disease in Q4 2019 […]
Sachs 20th Annual Biotech In Europe Forum
The 20th Annual Biotech in Europe (BEF) Forum is recognized as the leading international Stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-lPO, late-stage, and public companies. With leading investors, analysts, money managers, and pharma licensing executives supported […]
World Orphan Drug Congress
With over 1,500 attendees from 50+ countries, the 2020 edition of the World Orphan Drug Congress USA was held online on August 24-26. The conference has also become the industry defining meeting on Advanced Therapies for rare diseases, featuring discussions on clinical development, manufacturing, and commercialization of cell and gene therapies, as well as the […]
LSX Investival
Delta4 Reflects on the 2020 LSX Investival Showcase: A Landmark Event in Life Sciences Innovation In November 2020, the prestigious Waldorf Hilton Hotel in London hosted the LSX Investival Showcase, an eminent gathering in the life science and healthcare investment community. Delta4 was privileged to be among the distinguished participants in the 2020 Investival Showcase. […]
Life-Science Investment Days, Vienna
Delta4 Attends the Life Science Investment Days Event of 2019 The Life Science Investment Days event held in Vienna from November 7 to 8, 2019, was a significant conference aimed at bringing together investors, entrepreneurs, and thought leaders in the field of deep tech innovation, particularly within the healthcare and life science industries. This event […]
Biotech in Europe Forum (BEF)
Delta4’s Participation at the 19th Annual Biotech in Europe Forum: A Landmark Experience Delta4 was honored to attend the 19th Annual Biotech in Europe Forum in Basel, a premier event for the biotech and life science industry. This forum is renowned for its role as a key international platform for investment and partnership. At the […]